TABLE 1.
CFN medication summit delegate background
| Background | n (%) | HealthCare Sector | n (%) |
|---|---|---|---|
| Academic/Researcher | 25 (47.2) | University or research institute | 20 (37.7) |
| Health-care Professional | 14 (26.4) | No response | 8 (15.1) |
| Administrator | 4 (7.5) | Professional/advocacy/Not-for-profit organization | 7 (13.2) |
| Policy/Decision-Maker | 4 (7.5) | Hospital | 6 (11.3) |
| Frail Older Adult or Caregiver | 2 (3.8) | Residential/long-term care provider | 5 (9.4) |
| Quality/Patient Safety | 2 (3.8) | Government/health ministry | 3 (5.7) |
| Funding Agency | 2 (3.8) | Home/community care provider | 2 (3.8) |
| Industry—pharmaceutical company | 1 (1.9) | ||
| Industry—retail pharmacy | 1 (1.9) |